Adhesive capsulitis, commonly known as frozen shoulder, is a condition characterized by progressive inflammation and fibrosis of the shoulder joint capsule, leading to painful stiffening and a severe, global loss of shoulder range of motion. It is a self-limiting condition but can last for months to years and significantly impacts quality of life.
Frozen shoulder is one of the most important diagnoses to recognize promptly, both because it responds better to treatment in its early inflammatory stage and because it can masquerade as other shoulder conditions — and other conditions can trigger it. A significant rotator cuff tear that causes the patient to guard and avoid using the shoulder is a common precipitant, as is prolonged immobility following subacromial impingement or shoulder bursitis that goes undertreated. MRI is essential for separating true adhesive capsulitis from glenohumeral osteoarthritis, which can produce a similar pattern of global stiffness and is managed very differently.
Causes
Primary frozen shoulder.
In many cases, frozen shoulder develops without an identifiable precipitating cause — so-called idiopathic adhesive capsulitis. It most commonly affects women between the ages of 40 and 60, and involvement of the non-dominant shoulder is slightly more frequent. The underlying mechanism involves an abnormal fibroproliferative inflammatory response within the joint capsule — similar in some respects to Dupuytren's contracture — that leads to the deposition of dense collagen and scar tissue. This causes the normally elastic joint capsule to contract, lose volume (the axillary recess is disproportionately affected), and adhere to the humeral head, progressively restricting all planes of motion.
Secondary frozen shoulder.
Frozen shoulder frequently develops following a period of shoulder immobility due to injury, surgery, or systemic illness. Rotator cuff tears, proximal humerus fractures, and neurological events such as stroke are common precipitating events. Diabetes mellitus is the most significant systemic risk factor — diabetic patients are two to four times more likely to develop adhesive capsulitis, and their course is typically more severe, more bilateral, and more prolonged than in non-diabetic patients. This association is strong enough that a new diagnosis of frozen shoulder in a patient without a prior diabetes history warrants blood glucose screening. Thyroid disorders — both hypothyroidism and hyperthyroidism — and Parkinson's disease are also independently associated risk factors.
Symptoms
Frozen shoulder progresses through three overlapping clinical stages, though the boundaries between stages are gradual rather than abrupt. The freezing phase is characterized by the insidious onset of diffuse shoulder pain — often severe and particularly disruptive at night — with progressive loss of motion developing over weeks to months. Patients frequently cannot identify a precipitating injury. The frozen phase sees pain begin to plateau and decrease, but stiffness reaches its maximum, severely restricting both active and passive range of motion in all directions. Simple activities such as reaching overhead, fastening a bra clasp, or combing the hair become difficult or impossible. The thawing phase involves gradual, spontaneous improvement in range of motion over months to years as the capsule naturally loosens. Loss of external rotation is typically the earliest and most prominent motion deficit — and the last to fully return — making it the most reliable clinical marker for tracking progress.
Diagnosis
Diagnosis is primarily clinical, based on the characteristic pattern of diffuse shoulder pain and global restriction of both active and passive shoulder motion in all planes — the global passive restriction distinguishes frozen shoulder from rotator cuff tears, where passive motion is generally preserved. X-rays are typically normal, serving mainly to exclude glenohumeral arthritis and fractures. An MRI confirms the diagnosis by demonstrating thickening of the joint capsule — most reliably in the axillary recess — and increased T2 signal within the rotator interval and coracohumeral ligament, reflecting the active fibroinflammatory process. Capsular volume on MRI is typically reduced compared to the normal shoulder. Equally important, MRI definitively rules out rotator cuff tears, labral pathology, and glenohumeral arthritis that may present with overlapping symptoms and require entirely different management. When the diagnosis is genuinely uncertain clinically, MRI findings of capsular thickening with no significant rotator cuff or cartilage pathology are highly supportive of adhesive capsulitis.
Clinical stages
Doctors use clinical stages to describe the progression of frozen shoulder and guide treatment decisions at each phase.
- Stage 1 (Freezing): Pain dominant with active synovial inflammation, early capsular thickening, and progressive motion loss. Duration approximately 3–9 months. This is the stage most responsive to corticosteroid injection and anti-inflammatory treatment.
- Stage 2 (Frozen): Severe stiffness is the predominant feature; pain is present mainly at end-range motion. Dense capsular fibrosis has replaced the acute inflammatory process. Duration approximately 9–15 months. Physical therapy and hydrodilation are the primary interventions.
- Stage 3 (Thawing): Progressive spontaneous recovery of motion with minimal resting pain. The fibrotic capsule gradually remodels. Duration approximately 15–24 months. Most patients regain functional motion during this stage, though full restoration of motion is not universal.
Treatments
Treatment depends on the clinical stage, severity of symptoms, and the patient's response to initial interventions. Because frozen shoulder is ultimately self-limiting, treatment goals center on pain control and maintaining or accelerating the recovery of motion rather than altering the underlying biology of the condition.
Throughout all stages, consistent gentle daily stretching within tolerance and heat application before stretching are recommended to maintain capsular flexibility.
Stage 1 (Freezing): The primary goal is pain control to allow the patient to participate in rehabilitation. Oral anti-inflammatory medications provide modest benefit. Corticosteroid injections into the glenohumeral joint are most effective in this early inflammatory stage — multiple studies demonstrate significant short-term pain reduction and faster progression through the freezing phase when injections are administered early. Gentle physical therapy to maintain available range of motion and prevent further capsular contraction complements the injection protocol.
Stage 2 (Frozen)
Physical therapy with gentle, progressive stretching — particularly targeting external rotation and abduction — to prevent further stiffness and gradually reclaim range of motion is the foundation of treatment in the frozen phase. Hydrodilation (distension arthrography) — injecting a large volume of saline, often combined with corticosteroid and local anesthetic, into the joint under fluoroscopic or ultrasound guidance to mechanically stretch the contracted capsule — is an effective minimally invasive option that can accelerate the thawing process. Corticosteroid injections continue to provide adjunctive benefit for pain management.
Stage 3 (Thawing)
Continued physical therapy to optimize the recovery of motion and rebuild rotator cuff and periscapular strength as the capsule naturally remodels is the primary focus. Most patients regain functional range of motion during this stage without further intervention, though complete restoration of motion — particularly full external rotation — may take several additional months and is not guaranteed in all patients, particularly diabetics.
Persistent frozen shoulder not responding to conservative care
Surgery is reserved for patients who have not shown meaningful improvement despite 6–12 months of appropriate conservative management. Manipulation under anesthesia involves applying controlled force to the shoulder to mechanically rupture the adhesions while the patient is sedated — effective but associated with a small risk of fracture or labral injury. Arthroscopic capsular release — precisely dividing the contracted rotator interval, anterior capsule, and posterior capsule under direct visualization — is the most definitive surgical option, allowing controlled, targeted release of the specific structures limiting motion while avoiding the risks of blind manipulation. Both procedures are followed immediately by aggressive postoperative physical therapy to consolidate the motion gains achieved at surgery before re-adherence can occur.
Get an MRI to Confirm Your Diagnosis
Before surgical planning or starting treatment, a clear MRI diagnosis ensures the right path forward. First Look MRI offers self-pay Shoulder MRI scans — no doctor's order or insurance required — at our locations in Georgia, Texas, and Colorado.